Bleeding and thrombotic events in patients with colorectal cancer treated with bevacizumab and receiving novel oral anticoagulants and antiplatelet medications.

被引:0
|
作者
Rho, Shinji
Wang, Chris
Dehkordi, Seyed Hamed Hosseini
Sears, Jerod J.
Hu, Zishuo Ian
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
104
引用
收藏
页码:104 / 104
页数:1
相关论文
共 45 条
  • [41] Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
    Galeazzi, Roberta
    Olivieri, Fabiola
    Spazzafumo, Liana
    Rose, Giuseppina
    Montesanto, Alberto
    Giovagnetti, Simona
    Cecchini, Sara
    Malatesta, Gelsomina
    Di Pillo, Raffaele
    Antonicelli, Roberto
    DRUGS & AGING, 2018, 35 (07) : 649 - 656
  • [42] Analysis of totally implantable venous access port systems (TIVAPS) related adverse events (AEs) in metastatic colorectal cancer (mCRC) patients treated with and without bevacizumab.
    Tsushima, Takahiro
    Mori, Keita
    Yamazaki, Kentaro
    Hikosaka, Tomomi
    Funakoshi, Taro
    Tabuse, Hiroyuki
    Hamauchi, Satoshi
    Todaka, Akiko
    Yokota, Tomoya
    Machida, Nozomu
    Fukutomi, Akira
    Onozawa, Yusuke
    Boku, Narikazu
    Yasui, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Yamaguchi, Kazuhisa
    Taniguchi, Hiroya
    Komori, Azusa
    Narita, Yukiya
    Nitta, Sohei
    Nomura, Motoo
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    Mori, Keita
    Igarashi, Yoshinori
    BMC CANCER, 2015, 15
  • [44] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Kazuhisa Yamaguchi
    Hiroya Taniguchi
    Azusa Komori
    Yukiya Narita
    Sohei Nitta
    Motoo Nomura
    Shigenori Kadowaki
    Daisuke Takahari
    Takashi Ura
    Masashi Andoh
    Kei Muro
    Keita Mori
    Yoshinori Igarashi
    BMC Cancer, 15
  • [45] Phase II study of the novel oral Src-kinase inhibitor, AZD0530, in previously treated advanced colorectal cancer patients
    Eng, Cathy
    Kopetz, Scott
    Morris, Jeffrey
    Malik, Zulfiqar
    Stewart, David
    Chang, Hsiu-yin
    Ohinata, Aki
    Abbruzzese, James
    Gallick, Gary
    CANCER RESEARCH, 2008, 68 (09)